DKK1 functions as an inhibitor of the Wnt/β‐catenin signaling pathway, participating in the pathogenesis of diverse diseases, such as cancer, hypertension, neurodegenerative disorders, diabetic nephropathy, and arthritis [5, 6]. Here, DKK1 is linked to cancer.